Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified donor lymphocyte infusion to reduce infection in adult acute leukemia after allogeneic HSCT
IRCT20230801058996N4Phase 2Recruiting
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2024
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of donor lymphocytes in Acute Leukaemia, sponsored by Shahid Beheshti University of Medical Sciences. Started Jul 2024; status: recruiting.
02
Drugs
donor lymphocytes
03
Conditions
Acute Leukaemia
Beyond the preview
Go deeper on IRCT20230801058996N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230801058996N4.